Status In progress
Technology type Medicine
Decision Selected
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
Process STA Standard
ID number 6497

Provisional Schedule

Committee meeting: 1 11 November 2025
Expected publication 28 January 2026

Project Team

Project lead Louise Jafferally

Email enquiries

Stakeholders

Companies sponsors SIFI S.p.a. (polihexanide)
Others Department of Health and Social Care
  NHS England
Patient carer groups Fight for Sight
Professional groups Association of Optometrists
  Neonatal and Paediatric Pharmacists Group
  Royal College of Ophthalmologists
  Royal College of Physicians
Associated public health groups None
Comparator companies Thorton & Ross Ltd (propamidine) (confidentiality agreement not signed, not participating)
General commentators All Wales Therapeutics and Toxicology Centre
  British National Formulary
  Department of Health - Northern Ireland
  Healthcare Improvement Scotland
  Medicines and Healthcare products Regulatory Agency
  NHS Wales Joint Commissioning Committee
  Scottish Medicines Consortium
  Welsh Government
Relevant research groups None

Timeline

Key events during the development of the guidance:

Date Update
11 April 2025 Invitation to participate
26 March 2025 Topic routing was discussed at the NICE Prioritisation Board in March 2025. The Board concluded that the topic was suitable for a Technology Appraisal. Please see project documents for further details.
26 March 2025 Topic selection
22 January 2025 - 19 February 2025 Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: ID6497
22 January 2025 In progress. Scoping commenced.
25 October 2024 Awaiting development. Status change linked to Topic Selection Decision being set to Selected

For further information on our processes and methods, please see our CHTE processes and methods manual